Minimal clinically important difference for asthma endpoints: An expert consensus report

Matteo Bonini, Marcello Di Paolo, Diego Bagnasco, Ilaria Baiardini, Fulvio Braido, Marco Caminati, Elisiana Carpagnano, Marco Contoli, Angelo Corsico, Stefano Del Giacco, Enrico Heffler, Carlo Lombardi, Ilaria Menichini, Isabella Menichini, Manlio Milanese, Nicola Scichilone, Gianenrico Senna, Giorgio W. Canonica

Risultato della ricerca: Contributo in rivistaArticolo in rivista

7 Citazioni (Scopus)


Minimal clinically important difference (MCID) can be defined as the smallest change or difference in an outcome measure that is perceived as beneficial and would lead to a change in the patient’s medical management. The aim of the current expert consensus report is to provide a “state-of-the-art” review of the currently available literature evidence about MCID for end-points to monitor asthma control, in order to facilitate optimal disease management and identify unmet needs in the field to guide future research. A series of MCID cut-offs are currently available in literature and validated among populations of asthmatic patients, with most of the evidence focusing on outcomes as patient reported outcomes, lung function and exercise tolerance. On the contrary, only scant and partial data are available for inflammatory biomarkers. These clearly represent the most interesting target for future development in diagnosis and clinical management of asthma, particularly in view of the several biologic drugs in the pipeline, for which regulatory agencies will soon require personalised proof of efficacy and treatment response predictors.
Lingua originaleEnglish
pagine (da-a)1-14
Numero di pagine14
RivistaEuropean Respiratory Review
Stato di pubblicazionePubblicato - 2020


  • Anti-Asthmatic Agents
  • Asthma
  • Biomarkers
  • Bronchoconstriction
  • Consensus
  • Delphi Technique
  • Endpoint Determination
  • Humans
  • Inflammation Mediators
  • Lung
  • Minimal Clinically Important Difference
  • Predictive Value of Tests
  • Symptom Assessment
  • Treatment Outcome


Entra nei temi di ricerca di 'Minimal clinically important difference for asthma endpoints: An expert consensus report'. Insieme formano una fingerprint unica.

Cita questo